Concepedia

Author

Magdalena Sztachelska

AstraZeneca (United States)

Also Known As

Magdalena Sztachelska

1

Publications

10

Citations

1

H-Index

0

Concepts

All Affiliations

AstraZeneca (United States)
MS

About

Magdalena Sztachelska is an author at AstraZeneca (United States).

Magdalena Sztachelska

×

1

Publications

10

Citations

1

H-Index

YearCitations

Phase 1b/2, open-label dose-escalation and -expansion study evaluating trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with HER2+ and HER2-low gastric cancer (GC): DESTINY-Gastric03 (DG-03).

Yelena Y. Janjigian, Saeed Raoufmoghaddam, Magdalena Sztachelska,

Journal of Clinical Oncology

2024

10

Page 1